complement 2015(1).pdf
TRANSCRIPT
-
8/18/2019 complement 2015(1).pdf
1/31
Dr. Pratiwi S Gunawan, drg.,MKes.,PAH(K)
-
8/18/2019 complement 2015(1).pdf
2/31
-
8/18/2019 complement 2015(1).pdf
3/31
Complement was discovered by Jules Bordet as aheat-labile component of normal plasma thatcauses the opsonisation and killing of bacteria.
The complement system refers to a series of >20proteins, circulating in the blood and tissue fluids.
-
8/18/2019 complement 2015(1).pdf
4/31
Most of the proteins are normally inactive, but in responseto the recognition of molecular components ofmicroorganisms they become sequentially activated in anenzyme cascade – the activation of one protein
enzymatically cleaves and activates the next protein in thecascade.
-
8/18/2019 complement 2015(1).pdf
5/31
Complement can be activated via three different pathways(Figure 1), which can each cause the activation of C3,cleaving it into a large fragment, C3b, that acts as anopsonin, and a small fragment C3a (anaphylatoxin) that
promotes inflammation. Activated C3 can trigger the lyticpathway , which can damage the plasma membranes ofcells and some bacteria. C5a, produced by this process,attracts macrophages and neutrophils and also activates
mast cells.
-
8/18/2019 complement 2015(1).pdf
6/31
Continued next page…
Classical Pathway Alternative PathwayMannose Binding Lectin (MBL)
Pathway
Antigen-Antibody complex Activating surfaces Pathogen surfaces
C1
C4
C2
C3b C4
C2
MBL
MASP-1
MASP-2
C3 Convertase
C3b
C3b
C3a
C3
C5b-9
C5aC5
C5 Convertase
Lytic Pathway
C5bC6C7C8C9
Membrane attack complex (MAC)
Anaphylatoxin
Activates mast cells
Chemotactic
Factor B
Factor DFactor H
Factor I
-
8/18/2019 complement 2015(1).pdf
7/31
There are 3 major pathways1. Classical pathway triggered when IgM or certain
subclassed of IgG ( IgG1 & IgG3 )
2. Alternative pathway
triggered when abreakdown product of C3 hydrolis ( C3b ) isdeposited on the surface of microbe
3. Lectin pathway initiated in the absence of
antibody by the attachment of plasma mannose-binding lectin ( MBL ) to microba
-
8/18/2019 complement 2015(1).pdf
8/31
-
8/18/2019 complement 2015(1).pdf
9/31
A) Classical pathway:
- Complement is activated by antigen –antibody
complex (IgM or IgG)
- Fc portion of the antibody form a binding site for C1q
- The numerical sequence of the complement factors in theclassic pathway is:
C1q,r,s , C4, C2, C3, C5, C6, C7, C8, C9
-
8/18/2019 complement 2015(1).pdf
10/31
The reaction sequence divided into three
stages:1) Recognition stage:
- C1q act as the recognition element- It binds to Fc portion of IgM or IgG- The activated C1 molecule can cleave many C4
molec.
2) Activation stage:The complement components C4, C2, C3, C5, C6,C7,
C8, C9 participate in that order
3) Membrane attack stage:Complement components C5, C6, C7, C8, C9participate where cell membrane damage and cell
lysis occur
-
8/18/2019 complement 2015(1).pdf
11/31
This pathway is initiated by:
* Bacterial endotoxin, polysaccharide capsule,aggregates of IgE and properdin
* It starts at C3 then C5, C6, C7, C8, C9
* The complement compon. C1, C4, C2 are by-passed
* Antibodies are not required to initiateactivation of
this pathway
* This pathway provides a means of non-specificresistance
-
8/18/2019 complement 2015(1).pdf
12/31
Classical Pathway C1
C4 C2
C3 Alternative pathway
C5
C6
C7
C8
C9
Membrane damage
-
8/18/2019 complement 2015(1).pdf
13/31
Classic Pathway Alternative pathway
* Specific acquired immunity * Non-specific innate immunity
* Initiated by antibody * Bacterial endotoxin, capsule
* Interaction of all components * C1, C4, C2 are by-passed
* Properdin system not involved * Properdin system is involved
-
8/18/2019 complement 2015(1).pdf
14/31
-
8/18/2019 complement 2015(1).pdf
15/31
2) Opsonization:
- binding of complement proteins opsonin (C3b)
to surfaces of foreign organisms or particles
- Phagocytic cells express specific receptors for
opsonins, so promote phagocytosis
-
8/18/2019 complement 2015(1).pdf
16/31
3) Inflammatory response :
Small fragments released during complement
activation have several inflammatory actions:
a) C5a is chemotactic and attract neutrophiles andmacrophages
b) C5a activate phagocytes and neutrophils
C) C3,C4 and C5 are anaphylatoxins
Cause degranulation of mast cells and release of
histamine and other inflammatory mediators
-
8/18/2019 complement 2015(1).pdf
17/31
4) Immune complex clearance:- C3b facilitate binding of immune complex to severalsurfaces (erythrocytes) and enhance removal by liver
and spleen
- binds erythrocytes to blood vessels , make them as
easy prey for phagocytosis
- C3 deficiency associated with Immunocomplex
disease and susceptibility to recurrent infections
-
8/18/2019 complement 2015(1).pdf
18/31
5-Enhancement of antibody production:
- Binding of C3b to its receptors on activated B cells
(CR2) greatly enhances antibody production
- Patient who are deficient in C3b produce
much less antibody than normal individuals and
more susceptible to pyogenic infection
-
8/18/2019 complement 2015(1).pdf
19/31
-
8/18/2019 complement 2015(1).pdf
20/31
Harmful effects:
- If complement activate systematically on a largescale (Cm – ve bacilli)
- If activated by an autoimmune response to host cells
-
8/18/2019 complement 2015(1).pdf
21/31
The complement system plays a critical role ininflammation and defence against some bacterialinfections. Complement may also be activatedduring reactions against incompatible blood
transfusions, and during the damaging immuneresponses that accompany autoimmune disease.Deficiencies of individual complementcomponents or inhibitors of the system can lead to
a variety of diseases (Table ), which gives someindication of their role in protection againstdisease
-
8/18/2019 complement 2015(1).pdf
22/31
Complement Deficiency Disease
C3 and Factor B Severe bacterial infections
C3b-INA, C6 and C8 Severe Neisseria infections
Deficiencies of early C components C1, C4, C2. Systemic lupus erythematosus (SLE),
glomerulonephritis and polymyositis
C1-inhibitor Hereditary angioedema
-
8/18/2019 complement 2015(1).pdf
23/31
-
8/18/2019 complement 2015(1).pdf
24/31
-
8/18/2019 complement 2015(1).pdf
25/31
-
8/18/2019 complement 2015(1).pdf
26/31
-
8/18/2019 complement 2015(1).pdf
27/31
-
8/18/2019 complement 2015(1).pdf
28/31
-
8/18/2019 complement 2015(1).pdf
29/31
-
8/18/2019 complement 2015(1).pdf
30/31
-
8/18/2019 complement 2015(1).pdf
31/31
Thanks